This week's video: JCPenney's same-store sales fell 17% in Q1. Also, find out why Arena Pharmaceuticals and Toyota are both celebrating. More
-
-
Sponsored By:
-
Sponsored By:
ARNA
Recent Articles
Dow 15000! — Tuesday’s IP Market Recap
The Dow Jones Industrial Average closed above the 15000 mark for the first time ever, and the S&P 500 continued its record-setting rally. More
Belviq Is Not the Next Fen-Phen … Probably
Arena Pharmaceuticals' withdrawal of its European application for Belviq has turned the stock into a three-ring circus. Don't panic -- just get the facts straight. More
Data Drives the Rally — Tuesday’s IP Market Recap
Investors got a double good-news whammy on the housing and manufacturing fronts, though homebuilders didn't join in the market's broad-based gains. More
Late Stock Rally Pares Losses — Tuesday’s IP Market Recap
Continued concerns over Cyprus held stocks down most of the day, though a late rally cut back losses across the board and helped the Dow finish in the black. More
Keryx: An Important Biotech Reality Check in 5, 4, 3 …
This stock's tripling in the past month is your prototypical biotech "win." But if you don't lock in your gains now, you don't understand the game. More
Biotech Movers: Arena Gets Warned, MAP Gets an Offer
Among last week's highlights, Europe raises questions about Arena's obesity drug, Belviq, and Allergan offers $958 million for MAP Pharmaceuticals. More
